Type to search

Sanofi-GSK Next-generation COVID-19 Booster Delivers Strong Immune Response Against Variants of Concern, Including Omicron | Pharmtech Focus
Novavax COVID-19 Vaccine Nuvaxovid™ Provisionally Registered in Australia as a Booster in Individuals Aged 18 and Over | Pharmtech Focus
LumiraDx Achieves CE Mark for COVID-19 Antigen Test on Amira, its New Low-Cost Testing System | Pharmtech Focus